Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID J ROBINSON

Allopathic & Osteopathic Physicians Emergency Medicine

NPI
1831115922
CMS profile
985097
Location
HOUSTON, TX

General Payments · PY2018–2024

$153,101.73

  • Reported across 271 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$9,881.51

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Melinta Therapeutics, Inc. $5,906.32 1
Paratek Pharmaceuticals, Inc. $3,416.42 7
MeMed US, Inc. $417.40 3
BOSTON SCIENTIFIC CORPORATION $141.37 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $9,955.46 21
PY2019 $6,896.08 34
PY2020 $25,054.52 38
PY2021 $29,761.06 53
PY2022 $48,767.93 76
PY2023 $22,785.17 36
PY2024 $9,881.51 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boston Scientific Corporation $43.29 01/18/2024 Food and Beverage Undisputed 01/23/2026 1092617226 CMS
Boston Scientific Corporation $98.08 01/31/2024 Food and Beverage Undisputed 01/23/2026 1092617228 CMS
Melinta Therapeutics, LLC $5,906.32 02/22/2024 Consulting Fee Undisputed 01/23/2026 1140488373 CMS
MeMed US, Inc. $188.50 01/18/2024 Entertainment Undisputed 01/23/2026 1154918635 CMS
MeMed US, Inc. $125.03 05/01/2024 Food and Beverage Undisputed 01/23/2026 1154919014 CMS
MeMed US, Inc. $103.87 08/26/2024 Education Undisputed 01/23/2026 1154923005 CMS
Paratek Pharmaceuticals, Inc. $5.36 05/01/2024 Food and Beverage Undisputed 01/23/2026 1113916171 CMS
Paratek Pharmaceuticals, Inc. $36.18 08/09/2024 Travel and Lodging Undisputed 01/23/2026 1113916173 CMS
Paratek Pharmaceuticals, Inc. $8.20 08/09/2024 Food and Beverage Undisputed 01/23/2026 1113916175 CMS
Paratek Pharmaceuticals, Inc. $16.69 08/09/2024 Food and Beverage Undisputed 01/23/2026 1113916177 CMS
Paratek Pharmaceuticals, Inc. $1,505.00 08/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1113916179 CMS
Paratek Pharmaceuticals, Inc. $124.99 09/12/2024 Food and Beverage Undisputed 01/23/2026 1113916181 CMS
Paratek Pharmaceuticals, Inc. $1,720.00 09/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1113916183 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.